임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

18건 표시

3상모집 예정· Limited Stage Small-Cell Lung Cancer
제한기 소세포폐암 치료: 타를라타맙과 듀르발루맙 병합 vs. 듀르발루맙 단독
Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer
협력: 암젠
상세 →NCT07637513
초기 1상모집 예정· Abdominal Aortic Aneurysm
Mechanistic Clinical Trial of PCSK9 Inhibition for AAA
협력: 암젠
상세 →NCT06081153
1상모집 예정· Blinatumomab
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
협력: 암젠
상세 →NCT07283640
2상모집 예정· Phase 2 Study
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
협력: 암젠
상세 →NCT07192237
3상모집 예정· Autoimmune Hepatitis
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
리드: 암젠
상세 →NCT07598825
2상모집 예정· Phase II Clinical Trial
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
협력: 암젠
상세 →NCT07178912
2상모집 예정· Immunoglobulin G4-related Disease
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
리드: 암젠
상세 →NCT07222553
3상모집 예정· Obesity
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
리드: 암젠
상세 →NCT07684235
3상모집 예정· Obesity
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
리드: 암젠
상세 →NCT07684144
3상모집 예정· Primary Immune Thrombocytopenia
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
리드: 암젠
상세 →NCT07700238
2상모집 예정· Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
협력: 암젠
상세 →NCT07301424
2/3상모집 예정· Granulomatosis With Polyangiitis
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
협력: 암젠
상세 →NCT07176546
3상모집 예정· Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia
A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
리드: 암젠
상세 →NCT07223190
1/2상모집 예정· B-cell Acute Lymphoblastic Leukemia
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
상세 →NCT07313852
해당없음모집 예정· Atherosclerotic Cardiovascular Disease (ASCVD)
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
협력: 암젠
상세 →NCT07355894
단계 미표기모집 예정· Neuromyelitis Optica Spectrum Disorders
Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients
협력: 암젠
상세 →NCT07526298
2상모집 예정· Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma
Tarlatamab for Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma (TAURUS)
협력: 암젠
상세 →NCT06816394
2상모집 예정· Treatment Related Cancer
Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
협력: 암젠
상세 →NCT04034173

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.